• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头孢比普对葡萄球菌属菌株的活性。这些菌株源自与异物相关的感染。

Activity of ceftobiprole against Staphylococcus spec. isolates derived from foreign body associated infections.

作者信息

Hischebeth Gunnar T R, Gravius Sascha, Molitor Ernst, Kohlhof Hendrik, Hoerauf Achim, Hilgers Caecilia, Randau Thomas M

机构信息

Institute of Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, Sigmund-Freud-Str. 25, D-53127 Bonn, Germany.

Department of Orthopaedics and Trauma Surgery, University Hospital Bonn, Sigmund-Freud-Str. 25, D-53127 Bonn, Germany.

出版信息

Diagn Microbiol Infect Dis. 2018 Jun;91(2):175-178. doi: 10.1016/j.diagmicrobio.2018.01.010. Epub 2018 Jan 31.

DOI:10.1016/j.diagmicrobio.2018.01.010
PMID:29452992
Abstract

Antibiotic therapy is essential in foreign body associated infections. The treatment regime should aim at high tissue concentrations, high bioavailability, high biofilm penetration and good tolerance. We investigated whether the new cephalosporin ceftobiprole is active against clinical isolates from musculoskeletal foreign body associated infections. One hundred ninety-six staphylococci isolates (coagulase negative staphylococci and Staphylococcus aureus) derived from foreign body associated infections were tested towards susceptibility to ceftobiprole, using a test strip assay and broth microdilution. The MIC for all strains S. aureus indicated susceptibility to ceftobiprole. The MIC of only two strains of coagulase negative staphylococci was above 2 mg/L. Our results show that ceftobiprole might be considered as an off-label treatment option in foreign body associated infections.

摘要

抗生素治疗在与异物相关的感染中至关重要。治疗方案应旨在实现高组织浓度、高生物利用度、高生物膜穿透力和良好耐受性。我们研究了新型头孢菌素头孢比普对肌肉骨骼异物相关感染临床分离株是否有活性。使用试纸条法和肉汤微量稀释法,对196株源自异物相关感染的葡萄球菌分离株(凝固酶阴性葡萄球菌和金黄色葡萄球菌)进行了头孢比普敏感性测试。所有金黄色葡萄球菌菌株的最低抑菌浓度表明对头孢比普敏感。仅两株凝固酶阴性葡萄球菌的最低抑菌浓度高于2mg/L。我们的结果表明,头孢比普可被视为异物相关感染的一种超说明书治疗选择。

相似文献

1
Activity of ceftobiprole against Staphylococcus spec. isolates derived from foreign body associated infections.头孢比普对葡萄球菌属菌株的活性。这些菌株源自与异物相关的感染。
Diagn Microbiol Infect Dis. 2018 Jun;91(2):175-178. doi: 10.1016/j.diagmicrobio.2018.01.010. Epub 2018 Jan 31.
2
In vitro activity of novel anti-MRSA cephalosporins and comparator antimicrobial agents against staphylococci involved in prosthetic joint infections.新型抗耐甲氧西林金黄色葡萄球菌头孢菌素类药物和比较抗菌药物对假体关节感染相关葡萄球菌的体外活性。
J Glob Antimicrob Resist. 2018 Jun;13:221-225. doi: 10.1016/j.jgar.2018.01.022. Epub 2018 Feb 5.
3
In vitro activity of ceftobiprole on 440 Staphylococcus aureus strains isolated from bronchopulmonary infections.头孢比普对440株从支气管肺部感染分离出的金黄色葡萄球菌的体外活性。
Med Mal Infect. 2017 Mar;47(2):152-157. doi: 10.1016/j.medmal.2016.10.004. Epub 2016 Nov 14.
4
Comparative activity of ceftobiprole against coagulase-negative staphylococci from the BSAC Bacteraemia Surveillance Programme, 2013-2015.2013-2015 年,BSAC 菌血症监测项目中凝固酶阴性葡萄球菌的头孢托罗比对活性。
Eur J Clin Microbiol Infect Dis. 2018 Sep;37(9):1653-1659. doi: 10.1007/s10096-018-3295-6. Epub 2018 Jun 6.
5
In vitro activity of ceftobiprole against coagulase-negative staphylococci isolated in the USA.头孢比普在美国分离的凝固酶阴性葡萄球菌中的体外活性。
Int J Antimicrob Agents. 2008 Mar;31(3):294-6. doi: 10.1016/j.ijantimicag.2007.10.027. Epub 2008 Jan 3.
6
In vitro activity of ceftobiprole, daptomycin, linezolid, and vancomycin against methicillin-resistant staphylococci associated with endocarditis and bone and joint infection.头孢比普、达托霉素、利奈唑胺和万古霉素对与心内膜炎及骨和关节感染相关的耐甲氧西林葡萄球菌的体外活性。
Diagn Microbiol Infect Dis. 2007 Jul;58(3):363-5. doi: 10.1016/j.diagmicrobio.2007.02.010. Epub 2007 Apr 20.
7
Antimicrobial activity of ceftobiprole, a novel anti-methicillin-resistant Staphylococcus aureus cephalosporin, tested against contemporary pathogens: results from the SENTRY Antimicrobial Surveillance Program (2005-2006).头孢托罗培南(一种新型抗耐甲氧西林金黄色葡萄球菌头孢菌素)对当代病原体的抗菌活性:哨兵抗菌监测计划(2005 - 2006年)的结果
Diagn Microbiol Infect Dis. 2008 May;61(1):86-95. doi: 10.1016/j.diagmicrobio.2008.02.008. Epub 2008 Apr 2.
8
In-vitro profile of a new beta-lactam, ceftobiprole, with activity against methicillin-resistant Staphylococcus aureus.新型β-内酰胺类药物头孢比普对耐甲氧西林金黄色葡萄球菌的体外活性研究
Clin Microbiol Infect. 2007 Jun;13 Suppl 2:17-24. doi: 10.1111/j.1469-0691.2007.01722.x.
9
Activity of ceftobiprole against methicillin-resistant Staphylococcus aureus strains with reduced susceptibility to daptomycin, linezolid or vancomycin, and strains with defined SCCmec types.头孢洛林对耐甲氧西林金黄色葡萄球菌(MRSA)中达托霉素、利奈唑胺或万古霉素低水平耐药株,以及具有明确 SCCmec 型别的菌株的活性。
Int J Antimicrob Agents. 2014 Apr;43(4):323-7. doi: 10.1016/j.ijantimicag.2013.11.005. Epub 2013 Dec 11.
10
Comparative in vitro activity of ceftobiprole against staphylococci displaying normal and small-colony variant phenotypes.头孢托罗培南对呈现正常和小菌落变异体表型的葡萄球菌的体外活性比较
Antimicrob Agents Chemother. 2005 Oct;49(10):4372-4. doi: 10.1128/AAC.49.10.4372-4374.2005.

引用本文的文献

1
Antibiofilm approaches as a new paradigm for treating infections.抗生物膜方法作为一种治疗感染的新范例。
Prog Biomed Eng (Bristol). 2024 Apr;6(2). doi: 10.1088/2516-1091/ad1cd6. Epub 2024 Feb 9.
2
High Rate of Ceftobiprole Resistance among Clinical Methicillin-Resistant Isolates from a Hospital in Central Italy.意大利中部某医院耐甲氧西林金黄色葡萄球菌临床分离株中头孢妥仑耐药率较高。
Antimicrob Agents Chemother. 2018 Nov 26;62(12). doi: 10.1128/AAC.01663-18. Print 2018 Dec.